The synthesis of a library of bicyclic sultams incorporating the 1,5,2-dithiazepine 1,1-dioxide moiety is reported. Following scaffold synthesis via a one-pot sulfonylation/intramolecular thiaMichael protocol, several additional cyclization strategies have been realized enabling access to new bicyclic sultams.
Initial coupling of sultam 3b and Boc-protected amino acids started investigations of secondary cyclization pathways to form fused sultams (Scheme 2). Subsequently, Boc removal from coupling product 4 with TFA and quenching with water enabled in situ cyclization to 5. Three amino acids, leucine, methionine, and isoleucine were used to generate the three corresponding (R)-hexahydropyrazino[1, 2-b] [1,5,2]dithiazepine-6,9-dione 1,1-dioxides (5a-c) (Scheme 2).
A number of N-substituted (R)-dihydro-2H-imidazo[1, 5-b] [1,5,2]dithiazepine-6,8(3H,7H)-dione 1,1-dioxides (6a-d) were synthesized by treatment of 3b with isocyanates under basic condition (K 2 CO 3 ) in THF (Scheme 3). In this reaction, nucleophilic addition of sulfonamide to the isocyanate formed urea intermediates, which were shown to rapidly undergo in situ cyclization at room temperature with the neighboring ester group to afford the bicyclic product in good to excellent yields.
Alternatively, the ester group in 3b was reduced and mesylated to generate 7, which could be further reacted with secondary amines in simple nucleophilic substitutions to form 8, while reaction with primary amines afforded 9, and thus providing additional cyclization manifolds to explore. To this end, sultams 9a-c were reacted with 1,1'-carbonyldiimidazole (CDI), 1,2-dibromoethane, and paraformaldehyde to provide bicyclic products 10, 11, and 12, respectively (Scheme 4). It should be mentioned that the yield for compounds 11a-c were generally low. We envisioned it is because the difficulty in the alkylation of the sulfonamide due to its low nucleophilicity.
In conclusion, we have successfully developed five different strategies for the production of different bicyclic sultams, namely
To the best of our knowledge, these bicyclic systems containing the 1,5,2-dithiazepine 1,1-dioxide motif have not been previously reported. The compounds produced are under screening within the NIH Molecular Library Screening Network (NIH-MLSCN) and with other biological collaborators.
Experimental
All reactions were carried out under argon atmosphere. Stirring was achieved with ovendried magnetic stir bars. Et 2 O, toluene, THF and CH 2 Cl 2 were either purchased through Sigma-Aldrich or purified by passage through the Solv-Tek purification system employing activated Al 2 O 3 (Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518-1520). Et 3 N was purified by passage over basic alumina or distilled over CaH and stored over KOH. Flash column chromatography was performed with Sorbent Technologies (30930M-25, Silica Gel 60A, 40-63 um). Thin layer chromatography was performed on silica gel 60F254 plates (EM-5717, Merck). Deuterated solvents were purchased from Cambridge Isotope laboratories. 1 H, 13 C NMR spectra were recorded on a Bruker DRX-400 spectrometer operating at 400 MHz, 100 MHz respectively as well as a Bruker DRX-500 spectrometer operating at 500 MHz, 125 MHz respectively and a Avance AV-III 500 with a dual carbon/proton (CPDUL) cryoprobe operating at 500 MHz, 125 MHz respectively. Observed rotations at 589 nm were measured using AUTOPOL IV Model automatic polarimeter. Weights were taken on a Flexiweigh Automatic Weigher; weight tolerance +/-0.3mg. Samples were concentrated on a GeneVac EZ personal evaporator and placed under high vacuum for ≥ 2 hours before final weights were taken.
General procedure for the synthesis of 4 from scaffolds 3b
To a solution of 3b (0.5 mmol, 1 equiv.), Boc-protected amino acid (0.55 mmol, 1.1 equiv.) and DMAP (0.25 mmol, 0.5 equiv.) in CH 2 Cl 2 (5 mL) was added DCC (0.55 mmol, 1.1 equiv.). After the reaction was stirred at rt for 14 h, the reaction was quenched with the addition of H 2 O. The mixture was extracted with CH 2 Cl 2 , and the combined organic layers were washed with brine and dried (Na 2 SO 4 ). The crude product was purified via flash chromatography. 
General procedure for the synthesis of 5 from 4
To a solution of 4 (0.2 mmol, 1 equiv.) in CH 2 Cl 2 (1 mL) was added TFA (0.4 ml) at rt and kept stirring for 30 min, then added with H 2 O (4 ml). The reaction was stirred at rt for 48 h and the mixture was extracted with CH 2 Cl 2 . The combined organic layers were washed with sat. aq. NaHCO 3 , brine and dried (Na 2 SO 4 ). The crude product was purified via flash chromatography. (5aR,8S)-8-isobutylhexahydropyrazino[1,2-b][1,5,2]dithiazepine-6,9-dione 1,1-dioxide (5a (5aR,8S)-8-(2-(methylthio)ethyl)hexahydropyrazino[1,2-b][1,5,2]dithiazepine-6,9-dione 1,1 
General procedure for the synthesis of 6 from 3b
To a solution of 3b (0.2 mmol, 1 equiv.) in THF (2 mL) was added K 2 CO 3 (0.22 mmol, 1.1 equiv.), isocynate (0.22 mmol, 1.1 equiv.) at rt and kept stirring for 14 h. The reaction was quenched with the addition of H 2 O. The mixture was extracted with EtOAc and combined organic layers were washed with brine and dried (Na 2 SO 4 ). The crude product was purified via flash chromatography. (R)-7-cyclohexyldihydro-2H-imidazo[1,5-b][1,5,2]dithiazepine-6,8(3H,7H)-dione 1,1- 7-(2-methoxyphenyl)dihydro-2H-imidazo[1,5-b][1,5,2]dithiazepine-6,8(3H,7H)-dione 1,1 
General procedure for the synthesis of 7 from scaffolds 3b
A solution of NaBH 4 (24 mmol, 4 equiv.) in 50% EtOH/H 2 O (10 mL) was added to a suspension of 3b (6 mmol, 1 equiv.) in 50% EtOH/H 2 O (10 mL). After the reaction was stirred at 80 °C for 4 h, solvent was evaporated to afford the crude alcohol, which was purified via flash chromatography. Mesyl chloride (4.8 mmol, 1.2 equiv.) and Et 3 N (4.8 mmol, 1.2 equiv.) was added to a solution of the resulted alcohol (4 mmol, 1 equiv.) in CH 2 Cl 2 (20 mL) at 0 °C. The reaction was warmed to rt and stirred for 2 h, and solvent was removed under reduced pressure. The crude product was purified via flash chromatography. 
General procedure for the synthesis of 8 and 9 from 7
A solution of 7 (0.2 mmol, 1 equiv.) in MeCN (0.4 mL) was added amine (2 mmol, 10 equiv. for primary amine; 0.8 mmol, 4 equiv. for secondary amine). After the reaction was stirred at rt for 14 h, solvent was evaporated. The residue was dissolved in CH 2 Cl 2 , washed with H 2 O and brine, and dried over Na 2 SO 4 . The crude product was purified via flash chromatography. 3-(morpholinomethyl)-1,5,2-dithiazepane 1,1-dioxide (8a 3-(piperidin-1-ylmethyl)-1,5,2-dithiazepane 1,1-dioxide ( Bioactive thiazepanes.
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